Company Quick10K Filing
Acacia Diversified Holdings
10-Q 2020-06-30 Filed 2020-08-19
10-Q 2020-03-31 Filed 2020-08-07
10-K 2019-12-31 Filed 2020-06-26
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-15
S-1 2019-02-14 Public Filing
10-K 2018-12-31 Filed 2019-04-01
10-Q 2018-09-30 Filed 2018-11-05
10-Q 2018-06-30 Filed 2018-08-13
S-1 2018-04-18 Public Filing
10-Q 2018-03-31 Filed 2018-05-07
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-07
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-28
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-02-12
10-Q 2015-09-30 Filed 2015-11-10
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-20
10-Q 2014-09-30 Filed 2015-05-20
10-Q 2014-06-30 Filed 2015-05-20
10-Q 2014-03-31 Filed 2015-05-20
10-K 2013-12-31 Filed 2015-05-20
10-K 2013-12-31 Filed 2015-05-20
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-10
10-K 2012-12-31 Filed 2013-03-28
10-Q 2012-09-30 Filed 2013-02-22
10-Q 2012-06-30 Filed 2013-02-22
10-Q 2012-03-31 Filed 2013-02-22
10-K 2011-12-31 Filed 2013-02-22
10-Q 2010-03-31 Filed 2010-07-23
10-K 2009-12-31 Filed 2010-05-27
8-K 2020-08-06
8-K 2020-05-20
8-K 2020-05-20
8-K 2020-05-15
8-K 2020-05-13
8-K 2020-03-31
8-K 2020-03-26
8-K 2020-02-03
8-K 2019-05-29
8-K 2019-02-14
8-K 2018-07-30

Acacia Diversified Holdings Financials

ACCA Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash4220353071894243112159288550318112912313844116135372826495152567975
Accounts Receivable450321280009078992134158012363398952322513611710112
Inventory128240233130858580636058575754544544424027
PP&E1401314847494454232082376766464371366151996510495501590465485475657467428445731441412381
Assets1,3001,1291,0311,0241,22036222767281,3887858919151,0839561,1165232379267367696859281,023920607564547560697872830761
Accounts Payable65051419721720955471171562342531621551619223117706456629527676883102114104
Long-Term Debt61585424241111175253136122235180505002221214181716
Liabilities1,2231,1161,2121,1691,3681351732032749181,1901,2721,3251,3801,301480617621785593956479019631,0921,1951,3741,3641,6501,8371,6521,965
Stockholders' Equity7713-181-145-14922754-135-246470-405-381-410-297-345636462230863558210290281122-43-485-632-827-804-953-965-821-1,204
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue3613400000045103295329365274000226010761481336413492133028116414198
Cost of Revenue514865711517822510672414779957019585052678072169128
Gross Profit310292-555179152139168154-41-38-25363457642-40-3817491-29-31
R&D
SG&A206174924613912581106-101355751452297612223212416864538410283339320344209891207498
Tax000000000000000000000000000000000
Net Income-104-7422-17363-197-118-202-167-66-29412981-174-291-260-305-363-857-695-510-154-460-433-530-560-189-198-510-582
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating22713-895-117-131-3413-6128188-702-555-238-263-85-392-249-309-113-705-66-120-134-69-74-70
Cash Investing801,23780000-1-55-22,347-15-34-110-250-4-20-5-730-24-24-8-11
Cash Financing-251227-9-41-8-16-3-1559-16-13-4-7720-5018179431155385135-28-8721121589710577